Daawada dheef-shiid kiimikaadka ah ee loo yaqaan 'NDT', oo loo yaqaan 'NDT,' iyo 'porcine thyroid' - waa daawo tirtiran oo daawo ah oo ka soo jeeda qanjirada qallalan ee doofaarka.
Daawada dabiiciga ah ee dabiiciga ah ee loo yaqaan 'thyroid' ayaa ahaa daawadii ugu horeysay ee loo isticmaalo daaweynta hypothyroidism waxaana lagu heli karaa in ka badan qarni.
Isbedelka loo yaqaan 'Levothyroxine'
Qeybta hore ee qarnigii labaatanaad, dabiiciga ah ee loo yaqaan "thyroid" -ka, magaca 'Armor Thyroid' - ayaa ahaa daaweynta keliya ee loo heli karo hypothyroidism.
Sanadkii 1950-yadii, qaabka synthetic ee thyroxine (T4) ayaa la sameeyey. Thyroxine waa mid ka mid ah labada hormoon ee muhiimka ah ee qanjirka thyroid soo saaro. Tani waxay keentaa thyroxine oo loo yaqaan levothyroxine, ama l-thyroxine, waxaana lagu hormariyay doorasho daaweyn casri ah oo loogu talagalay hypothyroidism, marka la barbardhigo dabiiciga ah ee loo yaqaan 'thyroid'.
Si ka duwan levothyroxine, oo ah nooca loo yaqaan 'hormon T4', dabeecadda dabiiciga ah ee loo yaqaan 'thyroid' waxaa ku jira laba hormood oo muhiim ah oo tayroodh ah - T4 (thyroxine) iyo T3 (triiodotyronine) - sida kalcitonin, iyo walxo kale oo laga helo qanjirada dabiiciga ah . Qanjirka 'thyroid' caadiga ah wuxuu soo saaraa ugu horreyn T4 (hormoonka xajinta) iyo qaar ka mid ah T3, iyo T4 waxaa loo beddelaa T3, hormoonka firfircoon, si loogu isticmaalo unugyada iyo unugyada jidhka.
Levothyroxine wuxuu ahaa daaweynta doorbidida daaweynta caafimaadka caadiga ah tan iyo markii la hirgeliyey (Qaar ka mid ah noocyada caanka ah ee levothyroxine waxaa ka mid ah Synthroid, Tirosint , Unithroid, iyo Levoxyl).
Daawooyinka dabiiciga ah ee dabiiciga ah, oo ay ku jiraan magacyada calaamadaha Nature-Throid, Thyroid WP, Armor Thyroid, iyo daroogada Acella NPO Thyroid, ayaa weli ku jira suuqa. Daawooyinkani waxay sii wadaan inay ku dhaleeceynayaan naqshadeynta iyo dabka ka soo jeeda dhakhaatiirta caadiga ah iyo shirkadaha ku tartamaya tartanka, kuwaas oo calaamad u ah "gabow-gaboobay" oo dib loo dhigay.
Dhanka kale, qayb ka mid ah bukaan-socodka thyroid-ka ayaa sii waday in ay doorbidaan tayroodh dabiiciga ah oo la yareeyay levothyroxine, oo ay u badan tahay inay sabab u tahay jiritaanka hormoonada T4 iyo T3 ee qanjirada dabiiciga ah ee loo yaqaan 'thyroid', oo keliya T4 ee levothyroxine.
Astaamaha dabiiciga ah ee loo yaqaan 'Thyroid Versus Levothyroxine'
Arrinta dabiiciga ah ee dabiiciga ah ee loo yaqaan "tyroidyroxine" Inkastoo qarnigii nuska ahaa isticmaalka, ka dib markii la soo bandhigay levothyroxine, dhakhaatiirtu waxay inta badan ku doodeen isticmaalka daawooyinka tayroodh dabiiciga ah, oo sheegaya in aysan jirin daraasado muujinaya in ay tahay ammaan ama waxtar.
Taageerada qanjirada dabiiciga ah ee dabiiciga ah, waxaa jiray warar muhiim ah oo loogu talogalay bukaannada tufaaxa ee ka soo baxay shirkii sannadkii ee ururka Endocrine, kaas oo ka dhacay June 2013-kii San Francisco. Sida ku cad bandhigid uu sameeyay Thanh D. Hoang, DO, shaqaalaha xirfadlayaasha ah ee loo yaqaan 'endocrinologist' ee Walter Reed Xarunta Caafimaadka Qaranka ee Bethesda, MD, dabiiciga ah ee daaweynta tayroodhka dabiiciga ah ayaa ah mid lagu beddeli karo daweynta bedelka hoormoonka ee loo yaqaan 'levothyroxine'.
Daraasaddan, Dr. Hoang waxa uu sameeyay daraasad laba-indho la ', laba-indhoole ah, daraasad wareega ah si loo isbarbardhigo waxtarka dabiiciga ah ee dabiiciga ah ee loo yaqaan' tyrothyroxine 'sida daaweynta hypothyroidism.
Daraasadu waxay qiimaysay wadar ahaan 70 bukaan, kuwaas oo da'doodu u dhaxayso 18 jir ilaa 65, dhammaantoodna waxay qabeen cudurka hypothyroidism. Bukaannada ayaa si aan kala sooc lahayn loogu qoondeeyey koox ka mid ah daawooyinka loo yaqaan 'thyroid drug' ama levothyroxine, oo wadarta guud ahaan 16 toddobaad. Daraasadu waxay ahayd indho la'aan, taasoo macnaheedu yahay in bukaannadu aanay ogeyn labadaas daawo ee ay heleen.
Dhamaadka daraasaddan, bukaanka ayaa la waydiiyay nooca daawada ay doorbidayaan. Waxaa xiiso leh, in ku dhow kala badh kooxda-gaar ahaan, boqolkiiba 49-ayaa loo soo gudbiyay daaweynta tayroodh dabiiciga ah oo la qallajiyey, marka la barbardhigo qiyaastii boqolkiiba 19 oo doorbidaa levothyroxin.
Ilaa boqolkiiba 33 dadka bukaanka ah ma sheegin doorbid.
Danta gaar ahaaneed: Dr. Hoang ayaa sidoo kale sheegay in bukaannada qaata dabeecadda dabiiciga ah ee loo yaqaan 'thyroids' ay lumisay saddex rodol muddada muddada daraasadda, marka la barbardhigo bukaannada qaadata levothyroxine, oo aan lumin miisaanka.
Dr. Hoang ayaa u sheegay Indocrine maanta :
Ma helin wax isbeddel ah oo ku yimaada cabbirada dareemaha ee u dhexeeya labada daaweyn ... Waxaan hadda ognahay in hal maalin-kaste oo la kariyay ka-soo-saarka tayroodhka uu yahay daweyn kale oo ammaan ah oo loogu talagalay bukaanka qaba hypothyroidism oo aan ku qanacsaneyn daaweynta levothyroxin. Waa ikhtiyaarka loogu talagalay inay isku dayaan, iyo sidoo kale la nadiifiyo waxay keeni kartaa miisaan culus bukaankan sidoo kale.
> Isha:
> Hoang TD, et al. "Tijaabinta tayroodhka ee loo yaqaan 'thyroid' marka la barbar dhigo levothyroxine oo lagu daaweeyo hypothyroidism: waa la kala soocay, laba-indhoole ah, daraasad goynta." J Clin Endocrinol Metab. 2013 Maajo 98 (5): 1982-90. doi: 10.1210 / jc.2012-4107. Epub 2013 Mar 28.